Medibank Private Limited
ASX:MPL.AX
3.72 (AUD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 8,021.6 | 7,460.1 | 7,197.7 | 6,984.4 | 6,832.4 | 6,765 | 6,576.9 | 6,948.1 | 6,807.4 | 6,681.6 | 6,485.7 | 6,005 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 8,021.6 | 7,460.1 | 7,197.7 | 6,984.4 | 6,832.4 | 6,765 | 6,576.9 | 6,948.1 | 6,807.4 | 6,681.6 | 6,485.7 | 6,005 |
| Gross Profit Ratio
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 754.6 | 187.9 | 163.9 | 160.9 | 162.2 | 160.2 | 175.6 | 188.3 | 185.2 | 198.2 | 230.3 | 225.1 |
| Selling & Marketing Expenses
| 172.2 | 115.5 | 85.9 | 81.4 | 94.1 | 100.2 | 102.7 | 105.1 | 101.6 | 89.5 | 90.4 | 80.8 |
| SG&A
| 926.8 | 786.5 | 752 | 716.2 | 712.3 | 721 | 686.1 | 1,072.7 | 1,054.9 | 1,108.5 | 1,238.9 | 1,023.2 |
| Other Expenses
| -384.8 | -868.7 | -958.3 | -784.9 | -890.9 | -18.3 | -9.6 | -380.9 | -425.3 | 0 | 0 | 0 |
| Operating Expenses
| 384.8 | 868.7 | 958.3 | 784.9 | 890.9 | 6,148.7 | 5,978.5 | 6,319.4 | 6,261.1 | 6,285 | 6,268.8 | 5,690 |
| Operating Income
| -11 | 730.3 | 557.9 | 636.1 | 453.6 | 616.3 | 598.4 | 628.7 | 542.1 | 410.6 | 306.8 | 320.6 |
| Operating Income Ratio
| -0.001 | 0.098 | 0.078 | 0.091 | 0.066 | 0.091 | 0.091 | 0.09 | 0.08 | 0.061 | 0.047 | 0.053 |
| Total Other Income Expenses Net
| 718.8 | 728.5 | 555.5 | 633.3 | 450.2 | 616.3 | 598.4 | 628.7 | 4.2 | -14 | -89.9 | -5.6 |
| Income Before Tax
| 718.8 | 728.5 | 555.5 | 633.3 | 450.2 | 616.3 | 598.4 | 628.7 | 546.3 | 396.6 | 216.9 | 315 |
| Income Before Tax Ratio
| 0.09 | 0.098 | 0.077 | 0.091 | 0.066 | 0.091 | 0.091 | 0.09 | 0.08 | 0.059 | 0.033 | 0.052 |
| Income Tax Expense
| 215.3 | 216 | 166.1 | 191.1 | 134.6 | 178.6 | 174.2 | 179.2 | 128.7 | 111.3 | 86.1 | 82.3 |
| Net Income
| 496.4 | 511.1 | 393.9 | 441.2 | 315 | 458.7 | 445.1 | 449.5 | 417.6 | 285.3 | 130.8 | 232.7 |
| Net Income Ratio
| 0.062 | 0.069 | 0.055 | 0.063 | 0.046 | 0.068 | 0.068 | 0.065 | 0.061 | 0.043 | 0.02 | 0.039 |
| EPS
| 0.18 | 0.19 | 0.14 | 0.16 | 0.11 | 0.17 | 0.16 | 0.16 | 0.15 | 0.1 | 0.048 | 0.085 |
| EPS Diluted
| 0.18 | 0.19 | 0.14 | 0.16 | 0.11 | 0.17 | 0.16 | 0.16 | 0.15 | 0.1 | 0.048 | 0.085 |
| EBITDA
| 78.4 | -3.2 | 2.1 | -3.8 | -3.4 | -616.3 | -598.4 | -628.7 | 4.2 | -14 | -89.9 | -5.6 |
| EBITDA Ratio
| 0.01 | -0 | 0 | -0.001 | -0 | -0.091 | -0.091 | -0.09 | 0.001 | -0.002 | -0.014 | -0.001 |